| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |